Canopy Growth (TSX:WEED) Stock: What Should You Do After Its Major Correction?

Here are the key takeaways from Canopy Growth Corp.’s (TSX:WEED)(NYSE:CGC) first-quarter results, and what you should do.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

This could be the correction you’ve been waiting for! If you’re reading this article, you’re probably interested in participating in the growth of the cannabis industry.

Canopy Growth (TSX:WEED)(NYSE:CGC) is a top holding of marijuana funds and the stock is trading at half price from its 52-week high. That said, in the last five years, WEED stock has been, well, growing like a weed, resulting in a roughly 14-bagger despite the approximately 15% correction after reporting its first-quarter fiscal 2020 results on August 14.

The correction dragged down the stock to close to its technical support line of about $35 per share and is a good time to consider as a long-term investment for three to five years out.

Here are some key takeaways from the first-quarter results.

Revenue not as good as hoped

Net revenue increased by 249% to $90.5 million against the comparable quarter a year ago. This would have been amazing growth for most companies outside of the cannabis industry. However, it wasn’t enough to please the Street which estimated for $21.3 million higher in revenue.

Gigantic net loss on the surface

Another reason for the big drop was that Canopy Growth reported a huge net loss of -$1.28 billion or -$3.70 per share, which missed estimates by $3.29 per share.

It turns out the biggest contributor to the loss was a one-time, non-cash charge on the extinguishment of warrants held by Constellation Brands. Excluding this charge, the net loss would only have been -$105 million, or essentially $0.00 per share, which is much easier for investors to digest.

Gross margin compression

What might have been alarming is that the gross margin fell much lower to 15% from 43% a year ago.

Canopy Growth explained that the lower margin was primarily due to operating costs related to facilities that haven’t begun production yet and a shift in product mix.

Record harvest

On a positive note, Canopy Growth harvested 40,960 kilograms, an increase of 183% over the prior quarter and greatly exceeding its previous estimate of 34,000 kilograms.

This is significant because the Q1 harvest was the first full-scale harvest since it began retrofitting its large-scale greenhouse facilities in 2018, and with the majority of the work completed at the facilities, Canopy Growth will be shifting its focus on optimization to increase yield and lower cost.

Foolish takeaway

The gross margin compression is a temporary phenomenon, and the company is confident that it can return to being a high margin business and eventually transform into a profitable one.

At $36 and change per share as of writing, WEED stock trades at about 44 times sales and 2.6 times book, which is a huge discount of 65% and 49%, respectively, from its five-year multiples. So, now is an opportunistic entry point for investors with a big appetite for risk and volatility.

With some margin expansion over the next quarters, I wouldn’t be surprised if the stock traded at the $50 level again for gains of 37% or more!

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Kay Ng has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »